Best of Show Awards Winners Named at the Bio-IT World Conference & Expo
Products From Isilon Systems, Recentris, Tessella and Ingenuity Systems Recognized for Their Technical Innovation Driving Biomedical Research, Drug Discovery
BOSTON, MA -- (MARKET WIRE) -- May 2, 2007 -- Cambridge Healthtech Institute's Bio-IT World
magazine today announced that products from four bio-IT companies were
named Best of Show Awards winners at a ceremony held last night at the
World Trade Center in Boston during the Bio-IT World Conference & Expo:
The winning products included Ingenuity Pathways Analysis 5.0 from
Ingenuity Systems; Isilon IQ with OneFS 4.5 from Isilon Systems; CERF v
2.6 from Recentris and Adaptive Trials Simulation Toolkit v 1.0 from
Tessella.
Judged by a team of Bio-IT World magazine editors and highly regarded
industry experts, Best of Show Awards recognize new products which
demonstrate exceptional technology innovations across the life sciences
research, discovery and clinical trials process.
One company was selected within four technology categories. The following
winners were selected among 12 finalists, based on the products' technical
merit, functionality and innovation, and in-person presentations to the
judges at the show.
Life Science Software & Informatics
-- Ingenuity Systems; Ingenuity Pathways Analysis 5.0
Ingenuity Pathways Analysis (IPA) is a software application that enables
researchers to analyze and understand the complex biological and chemical
systems at the core of life science research. IPA's recent enhancements
significantly decrease the time from data generation to biological insight
by providing powerful new capabilities to address emerging industry needs.
IPA-Tox™ overcomes the data interpretation hurdle to deliver a focused
toxicity assessment of your candidate compounds, and IPA-Biomarker™ uses
filters to identify the most promising biomarker candidates and reveals the
underlying mechanistic connection between biomarkers and disease. These
capabilities integrate smoothly with IPA's core analysis capabilities,
which identify the pathways, regulatory networks, and biological processes
most perturbed in your dataset.
IPA's extensive knowledge base lets you search and explore information on
genes, chemicals, drugs, processes, and diseases. IPA 5.0 lets you find and
visualize the interactions between these components and build custom
pathways and gene lists for subsequent analysis. You can also use dynamic
pathways to understand how novel discoveries or recent findings are
relevant to well-established pathways. IPA 5.0 features the largest
knowledge base of its kind with the most descriptive structure, the highest
degree of accuracy, and the largest number of literature findings.
IPA allows you to easily communicate and collaborate with your colleagues.
IPA 5.0 lets you create and share high-quality interactive pathways which
provide access to underlying biological information, invite colleagues to
quickly review and understand your results using our new analysis
summaries, and easily integrate IPA 5.0 with in-house or 3rd party
software.
IT Infrastructure
-- Isilon Systems; Isilon IQ with OneFS 4.5
Isilon IQ delivers the industry's first single file system that unifies and
provides instant and ubiquitous access to the rapidly growing stores of
digital content and unstructured data, eliminating the cost and complexity
barriers of traditional storage architectures. OneFS 4.5 is a unified
operating system software layer that powers all of Isilon's award-winning
IQ family of clustered storage systems including the Isilon IQ 1920, 3000,
6000, Accelerator, and EX 6000.
With the release of its OneFS 4.5 operating system software, Isilon ushers
a number of innovations into the storage market, including the industry's
first clustered storage system to deliver one Petabyte of capacity and 10
Gigabytes per second of performance in a single file system and single
volume. Additionally, OneFS 4.5 includes the new state-of-the-art
FlexProtect-AP, featuring the storage industry's first implementation of
N+3 and N+4 data protection, enables customers to withstand the loss of
three or four simultaneous disks or nodes within very large clusters while
maintaining 100 percent availability of all data.
Notebooks & LIMS
-- Recentris; CERF v 2.6
Rescentris' Collaborative Electronic Research Framework™ (CERF) is a
secure, 21CFR11-compliant enterprise scientific information system designed
specifically for managing and sharing information in life sciences research
organizations. CERF combines a full-featured electronic lab notebook (ELN)
with scientific content management, an extensible knowledge and data
integration framework, and a science-driven informatics platform. Its
intuitive cross-platform desktop interface allows scientists to organize
and unify access to personal and shared content (e.g., documents,
spreadsheets, scientific data, reports), applications, and databases. The
CERF server provides central management of data storage, system functions
(i.e., security, business policies, administration, workflow), organization
of projects and experiments, content, annotations, and rich metadata, as
well as recordkeeping functions such as a PDF print engine and digital
signatures.
Rescentris has focused on delivering its CERF ELN and scientific content
management solution to biologists. In addition to being first to market
with an ELN for Biology, CERF is the only ELN system built not on legacy
code but rather on the next generation internet technology called 'semantic
web,' which brings inherent intelligence to R&D information and
future-proofs information assets. CERF enables R&D organizations to create,
organize, share, and exploit their knowledge assets. CERF provides a
unified desktop for knowledge workers and delivers R&D performance
improvements for multiple stakeholders throughout diverse life sciences
organizations. Rescentris CERF is used today by hundreds of researchers
worldwide to manage their research projects on a daily basis. CERF
customers today include biopharma companies, academic and clinical research
institutions, and government laboratories.
eClinical Technology
-- Tessella: Adaptive Trials Simulation Toolkit v 1.0
The Tessella 'Adaptive Trials Simulation Toolkit' will contain a range of
adaptive clinical trial models for simulating different adaptive methods
from phase 1 through to phase 3. The first release includes a Bayesian
model for phase 2 trials called 'NDLM dose finder.' and a 'Seamless Phase
2/3 Simulator.'
The toolkit is currently implemented as a desktop application with a GUI
component and separate computational models. The GUI allows the user to
easily set up the specification for their trial, choose their design
options and specify the different scenarios over which the design should be
simulated. Having then run the simulations the GUI displays graphs and
charts of the summary data so the expected operating characteristics of the
design can be studied. The GUI currently runs under Microsoft Windows.
The current implementation runs the simulations on the same hardware that
is running the GUI, but having the models implemented separately and as
simple command line applications means they are highly portable. We expect
future versions of the toolkit to allow the simulations to be run on
alternate hardware such as a centrally provided computing resource.
Best of Show Awards
Best of Show Award winners received honorary signage, an awards logo, and
an engraved award. They also will be featured on the Bio-IT World website
with additional coverage in an upcoming issue of the magazine. For
complete coverage of the awards visit www.bio-itworld.com.
About Cambridge Healthtech Institute - (www.chicorporate.com)
Your Life Science Network
Cambridge Healthtech Institute (CHI) is the industry leader offering the
preeminent source of information to the leading researchers and business
experts from top pharmaceutical, biotech and academic organizations.
Delivering an assortment of resources such as events, reports, publications
and e-newsletters, CHI portfolio of products includes Cambridge Healthtech
Institute Events, Pharmaceutical Strategy Series, Insight Pharma Reports,
Marketing Services, Bio-IT World Magazine and Cambridge Healthtech
Institute Media Group, which delivers numerous research area specific
e-newsletters.
Founded in 1992, Cambridge Healthtech Institute strives to develop quality
information sources that provide valuable new insights and competing points
of view while offering balanced coverage of the latest developments. Basic
research related to commercial implications is covered, with heavy emphasis
placed on end-user insights into new products and technology as well as
coverage on the strategy behind the business.
About Bio-IT World: (www.Bio-ITWorld.com)
Bio-IT World publishes critical information across a variety of media to
meet the needs of bio-IT professionals. Coverage focuses on the range of
tools and techniques, both computational and experimental, that increase
the efficiency and success of drug discovery, development, and clinical
trials.
Bio-IT World and accompanying website, www.Bio-ITWorld.com, as well as
content-specific e-newsletters (eCliniqua, Weekly Update, and Systems
Biology) impact over a hundred thousand life science professionals every
month. Established in September 2001, Bio-IT World has received more than
34 awards for editorial and design excellence.
Contact Information: Contact:
Lisa Scimemi
Ph: 781-972-5419
Email: Email Contact